MA (Cantab), MB BChir, PhD, FRCP, FRCPath
Professor Bloor is a Consultant Haematologist at The Christie and an Honorary Clinical Chair at the University of Manchester. He graduated in Medicine from the University of Cambridge in 1994 and completed his general medical training in Cambridge, followed by specialist haematology training at University College Hospital, London. As part of his training, he spent 4 years in Tony Green’s laboratory in Cambridge, leading to the award of a PhD in Molecular Haemopoiesis.
Since joining The Christie in 2006, Professor Bloor has held a number of senior clinical leadership roles. His clinical expertise includes the management of lymphoma and chronic lymphocytic leukaemia, stem cell transplantation, cellular therapies, and CAR-T therapy.
Professor Bloor’s research focus has been in haemato oncology and clinical trials. He was Clinical Director of the MAHSC Clinical Trials Unit at The Christie from 2009 to 2015 and has acted as principal or chief investigator on multiple trials in haemato-oncology and stem cell transplantation. He is a member of several national advisory and clinical trials groups, including the NCRI CLL Clinical Trials Committee, the NHS England Blood and Stem Cell Transplantation Clinical Reference Group, and the UK CLL Forum Executive Committee. He has also sat on medical advisory panels for national charities including Lymphoma Action, Leukaemia Care, and Blood Cancer UK.
In his role as Medical Director Future Christie, Professor Bloor collaborates with key stakeholders to define the future vision for the Trust. His portfolio includes strategic oversight of data, digital technology and innovation, ensuring these capabilities support modernised patient pathways, evidence-based decision making and improved patient outcomes.